UNITY Biotechnology Inc
Change company Symbol lookup
Select an option...
UBX UNITY Biotechnology Inc
DIDIY DiDi Global Inc
AWK American Water Works Company Inc
ASO Academy Sports and Outdoors Inc
GAB Gabelli Equity Trust
STRC Sarcos Technology and Robotics Corp
RLMD Relmada Therapeutics Inc
LMND Lemonade Inc
NAACW North Atlantic Acquisition Equity Warrant Exp 20 Oct 2025 *W EXP 10/20/2025
CG Carlyle Group Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Unity Biotechnology, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a portfolio of programs targeting specific biological mechanisms implicated in diseases of aging. The Company is focused on creating senolytic medicines to selectively eliminate senescent cells and thereby treat diseases of aging, such as ophthalmologic diseases, with the opportunity to explore neurology and other therapeutic areas. The Company's product includes UBX1325, UBX2089 and UBX2050. UBX1325 is an advanced lead drug candidate for age-related diseases of the eye, including diabetic macular edema (DME), age-related macular degeneration (AMD), and diabetic retinopathy (DR). UBX2089, an α-Klotho hormone drug candidate, is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications. UBX2050 is investigating fully human anti-Tie2 agonist monoclonal antibody.

Premarket

Last Trade
Delayed
$0.3992
-0.0097 (-2.37%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$0.4089
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
9,189

10-day average volume:
1,093,284
9,189
  • Prev Close
    0.4089
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    1.1M
  • Last (time)
    4:00p ET 09/27/22
  • Last (size)
    1
  • 52-Wk Range
    0.39 - 3.64
    LowHigh
  • (11/10/21 - 09/23/22)
    4.85%
  • 120.1%
  • Market Cap
    57.3M
  • Shares Outstanding
    140.2M
  • -0.95
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 16.83
  • (% of float 09/15/22)
    1.07

Latest News

September 19, 2022
8:00 am ET
Globe Newswire
August 31, 2022
8:00 am ET
Globe Newswire
August 18, 2022
10:45 am ET
PR Newswire
August 17, 2022
11:04 pm ET
Globe Newswire
August 16, 2022
4:01 pm ET
Globe Newswire
August 15, 2022
8:30 am ET
PR Newswire
August 12, 2022
8:30 am ET
PR Newswire
7:05 am ET
Globe Newswire
7:00 am ET
Globe Newswire
August 11, 2022
5:46 pm ET
Globe Newswire
July 12, 2022
4:00 pm ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.